Home buprenorphine/naloxone induction in primary care

Journal of General Internal Medicine

Volumn 24, Issue 2, 2009, Pages 226-232

  Lee, Joshua D ^a,b   Grossman, Ellie ^a   Dirocco, Danae ^a   Gourevitch, Marc N ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUPRENORPHINE; BUPRENORPHINE PLUS NALOXONE; METHADONE;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG MISUSE; DRUG SAFETY; FEASIBILITY STUDY; FEMALE; HEROIN DEPENDENCE; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; OPIATE ADDICTION; PATIENT ASSESSMENT; PATIENT EDUCATION; PRESCRIPTION; PRIMARY MEDICAL CARE; WITHDRAWAL SYNDROME;

ADULT; AMBULATORY CARE; BUPRENORPHINE; FEMALE; FOLLOW-UP STUDIES; HOME NURSING; HUMANS; MALE; MIDDLE AGED; NALOXONE; OPIOID-RELATED DISORDERS; PRIMARY HEALTH CARE;

EID: 58649094651     PISSN: 08848734     EISSN: 15251497     Source Type: Journal    
DOI: 10.1007/s11606-008-0866-8     Document Type: Article

References (30)

1. Center for Substance Abuse Treatment. Clinical guidelines for the use of buprenorphine in the treatment of opioid addiction: A Treatment Improvement Protocol (TIP) Series 40. Rockville, MD: Substance Abuse and Mental Health Services Administration, 2004.
2. EC Strain ML Stitzer IA Liebson GE Bigelow 2004 Comparison of buprenorphine and methadone in the treatment of opiate dependence Am J Psychiatry 151 7 1025 1030
3. RE Johnson MA Chutuape EC Strain SL Walsh ML Stitzer GE Bigelow 2000 A comparison of levomethadyl acetate, buprenorphine and methadone for opioid dependence N Engl J Med 343 18 1290 1297
4. R Mattick J Kimber C Breen M Davoli 2008 Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence Cochrane Database Syst Rev 16 2 CD002207
5. Substance Abuse and Mental Health Services Administration, Center for Substance Abuse Treatment. SAMHSA Evaluation of the Impact of the DATA Waiver Program. http://buprenorphine.samsha.gov/, accessed May 12, 2008.
6. B Kuehn 2005 Office-based treatment of opioid addiction achieving goals JAMA 294 7 784 786
7. LE Sullivan M Chawarski PG O'Connor RS Schottenfeld DA Fiellin 2005 The practice of office-based buprenorphine treatment of opioid dependence: is it associated with new patients entering into treatment? Drug Alcohol Depend 79 1 113 116
8. AY Walley JK Alperen DM Cheng 2008 Office-based management of opioid dependence with buprenorphine: clinical practices and barriers J Gen Intern Med 23 9 1393 1398
9. CO Cunningham HV Kunins RJ Roose RT Elam NL Sohler 2007 Barriers to obtaining waivers to prescribe buprenorphine for opioid addiction treatment among HIV physicians J Gen Intern Med 22 9 1325 1329
10. W Kissin C [tmp] McLeod J Sonnefeld A Stanton 2006 Experiences of a national sample of qualified addiction specialists who have and have not prescribed buprenorphine for opioid dependence J Addict Dis 25 4 91 103
11. Netherland J, Botsko M, Egan J, et al. Factors affecting willingness to provide buprenorphine treatment. J Subst Abuse Treat. In Press, available online 20 Aug 2008.
12. American Academy of Addiction Psychiatry. Buprenorphine in the treatment of opioid dependence. http://training.aaap.org/, accessed Nov. 14, 2008.
13. American Society of Addiction Medicine, Clinical Tools, Inc. Online buprenorphine training. http://buprenorphineCME.com, accessed Nov. 14, 2008.
14. DA Fiellin H Kleber JG Trumble-Hejduk AT [tmp] McLellan TR Kosten 2004 Consensus statement on office-based treatment of opioid dependence using buprenorphine J Subst Abuse Treat 27 2 153 159
15. IL Mintzer M Eisenberg M Terra C [tmp] MacVane DU Himmelstein S Woolhandler 2007 Treating opioid addiction with buprenorphine-naloxone in community-based primary care settings Ann Fam Med 5 2 146 150
16. DP Alford CT LaBelle JM Richardson 2007 Treating homeless opioid dependent patients with buprenorphine in an office-based setting J Gen Intern Med 22 2 171 176
17. MK Paasche-Orlow D Schillinger SM Greene EH Wagner 2006 How health care systems can begin to address the challenge of limited literacy J Gen Intern Med 21 8 884 887
18. WR Lange PJ Fudala EM Dax RE Johnson 1990 Safety and side-effects of buprenorphine in the clinical management of heroin addiction Drug Alc Dep 26 1 19 28
19. RE Johnson JH Jaffe PJ Fudala 1992 A controlled trial of buprenorphine for opioid dependence JAMA 267 20 2750 2755
20. W Ling C Charuvastra JF Collins 1998 Buprenorphine maintenance treatment of opiate dependence: a multicenter, randomized clinical trial Addiction 93 4 475 486
21. L Amass W Ling TE Freese 2004 Bringing buprenorphine-naloxone detoxification to community treatment providers: the NIDA Clinical Trials Network field experience Am J Addict 13 S1 S42 S66
22. MD Stein P Cioe PD Friedmann 2005 Buprenorphine retention in primary care J Gen Intern Med 20 11 1038 1041
23. JW Finch JB Kamien L Amass 2007 Two-year experience with buprenorphine-naloxone (Suboxone) for maintenance treatment of opioid dependence within a private practice setting J Addict Med 1 2 104 110
24. C Cunningham A Giovanniello G Sacajiu 2008 Buprenorphine treatment in an urban community health center: what to expect Fam Med 40 7 500 506
25. SL Walsh KL Preston GE Bigelow ML Stitzer 1995 Acute administration of buprenorphine in humans: partial agonist and blockade effects J Pharmacol Exp Ther 274 361 372
26. RE Johnson EC Strain L Amass 2003 Buprenorphine: how to use it right Drug Alcohol Depend 70 2 Suppl S59 S77
27. S Magura S Lee E Salsitz 2007 Outcomes of buprenorphine maintenance in office-based practice J Addict Dis 26 2 13 23
28. M Soyka C Zingg G Koler H Kuefner 2008 Retention rate and substance use in methadone and buprenorphine maintenance therapy and predictors of outcome: results from a randomized study Int J Neuropsychopharmacol 11 5 641 653
29. DA Fiellin MV Pantalon MC Chawarski 2006 Counseling plus buprenorphine-naloxone maintenance therapy for opioid dependence N Engl J Med 355 4 365 374
30. RS Schottenfeld MC Chawarski JR Pakes MV Pantalon KM Carroll TR Kosten 2005 Methadone versus buprenorphine with contingency management or performance feedback for cocaine and opioid dependence Am J Psych 162 2 340 349